Gut microbial and human genetic signatures of inflammatory bowel disease increase risk of comorbid mental disorders

被引:2
|
作者
Lee, Junho [1 ,2 ]
Oh, Shin Ju [3 ]
Ha, Eunji [1 ,2 ]
Shin, Ga Young [3 ]
Kim, Hyo Jong [3 ]
Kim, Kwangwoo [1 ,2 ]
Lee, Chang Kyun [3 ]
机构
[1] Kyung Hee Univ, Dept Biol, Seoul, South Korea
[2] Kyung Hee Univ, Dept Biomed & Pharmaceut Sci, Seoul, South Korea
[3] Kyung Hee Univ, Kyung Hee Univ Hosp, Ctr Crohns & Colitis, Dept Gastroenterol,Coll Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
DEPRESSION SCALE; HOSPITAL ANXIETY; ASSOCIATION; SUSCEPTIBILITY; DIVERSITY; EFFICIENT;
D O I
10.1038/s41525-024-00440-w
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The high prevalence of comorbid mental disorders (CMDs) in patients with inflammatory bowel disease (IBD) is well-documented. This study delves into the intricate CMD-IBD relationship through comprehensive analyses using human variants, gut microbiome, and anxiety/depression estimates from a cohort of 507 IBD patients and 75 controls. Notably, patients with IBD, especially those with CMD, exhibited lower diversity than controls. We identified 106 differentially abundant taxa (DATs) in IBD patients compared to controls and 21 DATs distinguishing CMD-affected from CMD-free IBD patients. Microbial IBD-risk scores, reflecting an individual's microbial burden for IBD, revealed a significant enrichment of IBD-risk signatures in CMD-affected patients compared to CMD-free patients. Additionally, there was an IBD-risk variant potentially regulating the abundance of an IBD/CMD-associated DAT, suggesting an interplay between IBD-risk variants and dysbiosis in CMD. Our investigation underscores the pivotal role of IBD-associated gut dysbiosis in predisposing IBD patients to CMD, partially through genetic variant-mediated mechanisms.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives
    Li, Mengfan
    Yang, Lijiao
    Mu, Chenlu
    Sun, Yue
    Gu, Yu
    Chen, Danfeng
    Liu, Tianyu
    Cao, Hailong
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 : 2402 - 2414
  • [42] Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease
    Sepehri, Shadi
    Kotlowski, Roman
    Bernstein, Charles N.
    Krouse, Denis O.
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (06) : 675 - 683
  • [43] Gastrointestinal infections are associated with unique gut microbiome signatures in patients with inflammatory bowel disease
    Axelrad, J.
    Hine, A.
    Devlin, J.
    Loke, P.
    Cadwell, K.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S644 - S645
  • [44] THE CLINICAL DETERMINANTS AFFECT GUT MICROBIAL PROFILE OF INFLAMMATORY BOWEL DISEASE PATIENTS
    Juillerat, Pascal
    Yilmaz, Bahtiyar
    Wiest, Reiner
    Rogler, Gerhard
    Macpherson, Andrew
    GASTROENTEROLOGY, 2018, 154 (06) : S1030 - S1030
  • [45] Systems Biology Approaches for Inflammatory Bowel Disease: Emphasis on Gut Microbial Metabolism
    Moco, Sofia
    Candela, Marco
    Chuang, Emil
    Draper, Colleen
    Cominetti, Ornella
    Montoliu, Ivan
    Barron, Denis
    Kussmann, Martin
    Brigidi, Patrizia
    Gionchetti, Paolo
    Martin, Francois-Pierre J.
    INFLAMMATORY BOWEL DISEASES, 2014, 20 (11) : 2104 - 2114
  • [46] Reply: On the Risk of Neurological Disorders in Patients With Inflammatory Bowel Disease
    Zamani, Mohammad
    Malekzadeh, Reza
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (07) : 1227 - 1227
  • [47] Functional disorders in chronic inflammatory bowel disease: the gut-brain axis
    Begre, Stefan
    Fox, Mark
    Jordi, Sebastian Bruno Ulrich
    Misselwitz, Benjamin
    INNERE MEDIZIN, 2025, 66 (02): : 181 - 189
  • [48] Gut microbiome as a potential biomarker of cancer risk in inflammatory bowel disease
    Jones, Ryan Lane
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2022, 26 (01): : 40 - 43
  • [49] Inflammatory Bowel Disease Environmental Risk Factors: Diet and Gut Microbiota
    Altajar S.
    Moss A.
    Current Gastroenterology Reports, 2020, 22 (12)
  • [50] Prevalence and Effect of Genetic Risk of Thromboembolic Disease in Inflammatory Bowel Disease
    Naito, Takeo
    Botwin, Gregory J.
    Haritunians, Talin
    Li, Dalin
    Yang, Shaohong
    Khrom, Michelle
    Braun, Jonathan
    Abbou, Lisa
    Mengesha, Emebet
    Stevens, Christine
    Masamune, Atsushi
    Daly, Mark
    McGovern, Dermot P. B.
    GASTROENTEROLOGY, 2021, 160 (03) : 771 - +